BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12724582)

  • 1. Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.
    Mehta SR
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():17B-20B; discussion 20B-21B. PubMed ID: 12724582
    [No Abstract]   [Full Text] [Related]  

  • 2. Can clopidogrel and aspirin lower mortality in patients with acute myocardial infarction?
    Bhatt DL
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):182-3. PubMed ID: 16568122
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
    Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
    Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
    MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study].
    Gaciong Z
    Kardiol Pol; 2006 May; 64(5):548-51; discussion 551-2. PubMed ID: 16752345
    [No Abstract]   [Full Text] [Related]  

  • 7. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
    L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG
    Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P; Stenestrand U; Malmberg K; Jönsson B
    Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Peters RJ; Mehta SR; Fox KA; Zhao F; Lewis BS; Kopecky SL; Diaz R; Commerford PJ; Valentin V; Yusuf S;
    Circulation; 2003 Oct; 108(14):1682-7. PubMed ID: 14504182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [More modest use in secondary prevention, risky in primary prevention].
    MMW Fortschr Med; 2006 Apr; 148(14):10-1. PubMed ID: 16669270
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised controlled trial evaluating the role of tirofiban in high-risk non-ST elevation acute coronary syndromes: an East Indian perspective.
    Bhattacharya R; Pani A; Dutta D; Basak S; Gangopadhyay S; Das Baksi S; Sarkar RN
    Singapore Med J; 2010 Jul; 51(7):558-64. PubMed ID: 20730395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
    J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does combined clopidogrel and statin therapy benefit patients with non-ST-elevation myocardial infarction?
    Altman R
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):558-9. PubMed ID: 16258563
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
    Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
    Chen WH; Lee PY; Ng W; Tse HF; Lau CP
    J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
    Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.